Wolverine Trading, LLC Akero Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $103,558 - $458,003	9,100 Added 91.92%	19,000 $443,000
Q3 2023 Nov 15, 2023	BUY	$41.19 - $52.25 $57,666 - $73,150	1,400 Added 16.47%	9,900 $500,000
Q2 2023 Aug 23, 2023	SELL	$36.89 - $56.88 $22,134 - $34,128	-600 Reduced 6.59%	8,500 $396,000
Q1 2023 May 15, 2023	SELL	$37.27 - $50.24 $309,341 - $416,992	-8,300 Reduced 47.7%	9,100 $344,000
Q4 2022 Feb 14, 2023	BUY	$33.44 - $54.8 $581,856 - $953,520	17,400 New	17,400 $954,000

170

72.7M

178K

164K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.38B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.